PERC, which stands for Pediatric Epilepsies & Rare CNS Gene Editing Platform, is a program designed to expedite the creation of precise genetic treatments for severe childhood neurologic conditions that currently lack effective remedies. Located in BAR HARBOR, Maine, the initiative was announced on July 9, 2026. The Jackson Laboratory is spearheading this effort to address the pressing need for solutions in the realm of pediatric epilepsies and other rare central nervous system disorders. This platform is set to harness cutting-edge gene editing technologies to develop targeted therapies, potentially transforming the landscape of treatment for these debilitating diseases.